CF PharmTech, Inc. (HKG:2652)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
21.70
-0.76 (-3.38%)
At close: Apr 29, 2026

CF PharmTech Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
21.0931.73-49.4-131.73
Depreciation & Amortization
58.8552.9638.227.9
Other Amortization
1.341.20.691.9
Loss (Gain) From Sale of Assets
0.630.390.810.01
Asset Writedown & Restructuring Costs
----0.3
Loss (Gain) From Sale of Investments
-7.05-8.68-7.99-13.35
Loss (Gain) on Equity Investments
0.070.1--
Stock-Based Compensation
7.8216.6815.9214.24
Provision & Write-off of Bad Debts
---0.06
Other Operating Activities
1.82-8.22-27.41-4.86
Change in Accounts Receivable
-25.556.39-8.26-3.38
Change in Inventory
-12.97-10.66-8.51-15.99
Change in Accounts Payable
7.430.18-5.9731.27
Change in Unearned Revenue
-3.5218.59-0.42-
Change in Other Net Operating Assets
46.515.6497.81-
Operating Cash Flow
96.46116.2945.47-156.69
Operating Cash Flow Growth
-17.05%155.77%--
Capital Expenditures
-167.66-114.64-91.19-91.25
Sale (Purchase) of Intangibles
-32.99-23.7-15.74-
Investment in Securities
6514.76-34375.92
Other Investing Activities
22.21-4.08-10.516.4
Investing Cash Flow
-113.44-127.65-151.42301.06
Long-Term Debt Issued
54.820--
Long-Term Debt Repaid
-5.78-3.55-4.01-
Net Debt Issued (Repaid)
49.0216.45-4.01-
Other Financing Activities
-20.33-8.58-1.4-4.5
Financing Cash Flow
28.697.88-5.41-4.5
Foreign Exchange Rate Adjustments
-0.39-0.742.92-1.75
Net Cash Flow
11.33-4.23-108.45138.11
Free Cash Flow
-71.21.65-45.72-247.95
Free Cash Flow Margin
-11.72%0.30%-13.10%-590.55%
Free Cash Flow Per Share
-0.190.00-0.12-
Cash Interest Paid
1.52---
Cash Income Tax Paid
----15.79
Levered Free Cash Flow
-95.5845.97-135.42-207.07
Unlevered Free Cash Flow
-94.4746.07-135.32-206.98
Change in Working Capital
11.8930.1474.65-50.57
Source: S&P Global Market Intelligence. Standard template. Financial Sources.